From: The ideal approach for treatment of cT1N+ and cT2Nany esophageal cancer.: a NCDB analysis
 | NT(N=2289) | AT(N=285) | CT(N=221) | p valueα | p valueβ |
---|---|---|---|---|---|
30-d mortality | 83 (3.6%) | 2 (0.7%) | 2 (0.9%) | 0.004 | 1.000 |
90-d mortality | 185 (8.1%) | 3 (1.1%) | 9 (4.1%) | <0.001 | 0.026 |